Skip to main content
永顺生物 logo

永顺生物 — Investor Relations & Filings

Ticker · 920729 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2022-03-22 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920729

About 永顺生物

https://www.winsun-gd.com/

Guangdong Winsun Bio-Pharmaceutical Co., Ltd. is a specialized enterprise focused on the research, development, production, and distribution of veterinary biological products. The company primarily develops vaccines for livestock and poultry, with a significant emphasis on swine and avian health. Its product portfolio includes live and inactivated vaccines targeting major diseases such as classical swine fever, porcine reproductive and respiratory syndrome (PRRS), and avian influenza. Winsun Bio-Pharmaceutical leverages advanced biotechnology to provide comprehensive animal disease prevention and control solutions. The company maintains a strong focus on technological innovation and quality management, operating multiple GMP-certified production lines to ensure the efficacy and safety of its biological preparations. Its research initiatives often involve collaborations with academic institutions to advance veterinary medicine and support the animal husbandry sector.

Recent filings

Filing Released Lang Actions
2021年度非经营性资金占用及其他关联资金往来情况的专项审计说明
Regulatory Filings
2022-03-22 Chinese
2021年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as an "年度报告摘要" which translates to "Annual Report Summary" for the year 2021. It contains detailed financial data, business descriptions, shareholder information, and operational details typical of an annual report. The document length is 8470 characters, which is substantial and contains actual financial and operational data, not just an announcement or a brief summary. It also includes an audit opinion mention from an accounting firm, which is common in annual reports. Therefore, this document is the actual Annual Report or a substantial summary of it, not merely an announcement or a presentation. Hence, the appropriate classification is Annual Report (10-K). FY 2021
2022-03-22 Chinese
2021年度审计报告
Regulatory Filings
2022-03-22 Chinese
中信建投证券股份有限公司关于广东永顺生物制药股份有限公司公司治理自查和规范活动的专项核查意见
Regulatory Filings
2022-03-22 Chinese
2021年年度报告
Annual Report Classification · 100% confidence The document is titled '年度报告 2021' which translates to 'Annual Report 2021'. It contains detailed sections typical of an annual report such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, internal control, investor protection, and financial accounting reports. The document includes audited financial data, management's discussion and analysis, risk disclosures, and other comprehensive information covering the full fiscal year 2021. The length of the document (15,000 characters) and the depth of content confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2022-03-22 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the seventh meeting of the fourth board of directors of Guangdong Yongshun Biopharmaceutical Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to other reports and announcements (such as the 2021 Annual Report, financial reports, and credit facility applications) that are disclosed elsewhere. The document primarily serves as a formal record of board decisions and meeting proceedings rather than the full reports themselves. It does not contain substantive financial data or full report content but rather resolutions and approvals related to various reports and proposals. Therefore, it fits best into the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2022-03-22 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.